vs
Immunocore Holdings plc（IMCR）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是Immunocore Holdings plc的1.8倍（$188.3M vs $104.5M），Immunocore Holdings plc同比增速更快（24.3% vs -21.9%），过去两年Immunocore Holdings plc的营收复合增速更高（21.7% vs -15.4%）
Immunocore是一家处于商业化阶段的全球生物技术企业，总部位于英国牛津郡，依托可溶性T细胞受体技术深耕生物药物的研发领域，其创新技术平台为肿瘤、感染性疾病、自身免疫性疾病等多领域的新药开发提供支撑。
IMCR vs RILY — 直观对比
营收规模更大
RILY
是对方的1.8倍
$104.5M
营收增速更快
IMCR
高出46.2%
-21.9%
两年增速更快
IMCR
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.5M | $188.3M |
| 净利润 | — | $90.3M |
| 毛利率 | 97.4% | 79.5% |
| 营业利润率 | -18.8% | 32.3% |
| 净利率 | — | 47.9% |
| 营收同比 | 24.3% | -21.9% |
| 净利润同比 | — | 1710.8% |
| 每股收益（稀释后） | $-0.61 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMCRRILY
| Q4 25 | $104.5M | $188.3M | ||
| Q3 25 | $103.7M | $215.3M | ||
| Q2 25 | $98.0M | $188.2M | ||
| Q1 25 | $93.9M | $197.2M | ||
| Q4 24 | $84.1M | $241.0M | ||
| Q3 24 | $80.2M | $225.5M | ||
| Q2 24 | $75.4M | $256.0M | ||
| Q1 24 | $70.5M | $263.4M |
净利润IMCRRILY
| Q4 25 | — | $90.3M | ||
| Q3 25 | $-177.0K | $91.1M | ||
| Q2 25 | $-10.3M | $139.5M | ||
| Q1 25 | $5.0M | $-10.0M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $8.7M | $-284.4M | ||
| Q2 24 | $-11.6M | $-433.6M | ||
| Q1 24 | $-24.4M | $-49.2M |
毛利率IMCRRILY
| Q4 25 | 97.4% | 79.5% | ||
| Q3 25 | 99.5% | 83.7% | ||
| Q2 25 | 98.9% | 81.3% | ||
| Q1 25 | 99.1% | 81.4% | ||
| Q4 24 | 99.6% | 79.8% | ||
| Q3 24 | 99.4% | 82.1% | ||
| Q2 24 | 97.7% | 84.5% | ||
| Q1 24 | 99.7% | 85.3% |
营业利润率IMCRRILY
| Q4 25 | -18.8% | 32.3% | ||
| Q3 25 | -6.9% | 30.4% | ||
| Q2 25 | -15.2% | 5.7% | ||
| Q1 25 | -3.9% | -31.2% | ||
| Q4 24 | -23.1% | -69.2% | ||
| Q3 24 | -10.6% | -36.4% | ||
| Q2 24 | -21.2% | -90.8% | ||
| Q1 24 | -37.6% | -6.1% |
净利率IMCRRILY
| Q4 25 | — | 47.9% | ||
| Q3 25 | -0.2% | 42.3% | ||
| Q2 25 | -10.5% | 74.1% | ||
| Q1 25 | 5.4% | -5.1% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | 10.9% | -126.1% | ||
| Q2 24 | -15.4% | -169.4% | ||
| Q1 24 | -34.7% | -18.7% |
每股收益（稀释后）IMCRRILY
| Q4 25 | $-0.61 | $2.78 | ||
| Q3 25 | $0.00 | $2.91 | ||
| Q2 25 | $-0.20 | $4.50 | ||
| Q1 25 | $0.10 | $-0.39 | ||
| Q4 24 | $-0.47 | $-0.01 | ||
| Q3 24 | $0.17 | $-9.39 | ||
| Q2 24 | $-0.23 | $-14.35 | ||
| Q1 24 | $-0.49 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $864.2M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $381.0M | $-171.5M |
| 总资产 | $1.1B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMCRRILY
| Q4 25 | $864.2M | $226.6M | ||
| Q3 25 | $892.4M | $184.2M | ||
| Q2 25 | $882.8M | $267.4M | ||
| Q1 25 | $837.0M | $138.3M | ||
| Q4 24 | $820.4M | $146.9M | ||
| Q3 24 | $901.3M | $159.2M | ||
| Q2 24 | $859.6M | $236.9M | ||
| Q1 24 | $832.8M | $190.7M |
总债务IMCRRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $438.7M | — | ||
| Q2 24 | $452.5M | — | ||
| Q1 24 | $452.5M | — |
股东权益IMCRRILY
| Q4 25 | $381.0M | $-171.5M | ||
| Q3 25 | $396.6M | $-260.5M | ||
| Q2 25 | $388.5M | $-351.7M | ||
| Q1 25 | $378.5M | $-496.8M | ||
| Q4 24 | $360.7M | $-488.2M | ||
| Q3 24 | $377.8M | $-497.6M | ||
| Q2 24 | $359.1M | $-218.3M | ||
| Q1 24 | $359.5M | $228.4M |
总资产IMCRRILY
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $1.0B | $1.8B | ||
| Q3 24 | $1.1B | $2.2B | ||
| Q2 24 | $1.0B | $3.2B | ||
| Q1 24 | $994.0M | $5.0B |
负债/权益比IMCRRILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.26× | — | ||
| Q1 24 | 1.26× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.7M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-35.5M | — |
| 自由现金流率自由现金流/营收 | -34.0% | — |
| 资本支出强度资本支出/营收 | 2.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | $-15.1M | — |
8季度趋势，按日历期对齐
经营现金流IMCRRILY
| Q4 25 | $-32.7M | $26.2M | ||
| Q3 25 | $-4.5M | $-60.6M | ||
| Q2 25 | $26.0M | $-25.6M | ||
| Q1 25 | $435.0K | $184.0K | ||
| Q4 24 | $-14.0M | $-2.7M | ||
| Q3 24 | $21.1M | $19.5M | ||
| Q2 24 | $23.5M | $111.5M | ||
| Q1 24 | $-4.6M | $135.4M |
自由现金流IMCRRILY
| Q4 25 | $-35.5M | — | ||
| Q3 25 | $-5.2M | — | ||
| Q2 25 | $25.6M | — | ||
| Q1 25 | $137.0K | — | ||
| Q4 24 | $-17.5M | — | ||
| Q3 24 | $20.3M | — | ||
| Q2 24 | $23.1M | — | ||
| Q1 24 | $-5.0M | — |
自由现金流率IMCRRILY
| Q4 25 | -34.0% | — | ||
| Q3 25 | -5.0% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | -20.9% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 30.7% | — | ||
| Q1 24 | -7.1% | — |
资本支出强度IMCRRILY
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.6% | — |
现金转化率IMCRRILY
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMCR
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
